Tüdőrák: vizsgálatok itt: Németország
182 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
- Where
- Essen, Esslingen am Neckar, Giessen, Leipzig, Mainz, Mannheim
- Életkor
- 18 év and over
- People
- 686 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06899126 · EU 2024-515658-26-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- Where
- Berlin, Brunswick, Cologne, Dortmund, Erfurt, Essen, Gera, Kaiserslautern, Landshut, Langen (Hessen), Luebeck, Rosenheim, Solingen, Wangen Im Allgaeu, Wiesbaden
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07361510 · EU 2025-523586-18-00 - 2. fázisNot yet taking people in NémetországA Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Where
- Cologne, Frankfurt Am Main, Halle (Saale), Homburg, Marburg, Stuttgart
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07680764 · EU 2026-525170-19-00 - 1. fázisTaking peopleA phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
- Where
- Cologne, Essen
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-518348-19-00 - 3. fázisTaking peopleStudy of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
- Where
- Berlin, Bochum, Chemnitz, Esslingen am Neckar, Hamburg, Löwenstein, Minden, Munich
- Életkor
- 18 év and over
- People
- 695 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06801834 - 3. fázisTaking peopleA Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer
- Where
- Berlin, Bonn, Chemnitz, Cologne, Dresden, Frankfurt Am Main, Gauting, Halle (saale), Hamburg, Luebeck, Munich
- Életkor
- 18 év and over
- People
- 263 worldwide
- Run by
- Zai Lab (US) LLC
See details and how to join2025-522818-23-00 - 1/2. fázisTaking peopleStudy of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Where
- Berlin, Cologne, Dresden, Frankfurt Am Main, Heidelberg
- Életkor
- 18 év and over
- People
- 616 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06162221 · EU 2025-521147-21-00 - 2. fázisTaking peopleTrial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
- Where
- Bielefeld, Essen, Großhansdorf, Heidelberg, Moers, Würzburg
- Életkor
- 18 év and over
- People
- 107 worldwide
- Run by
- CatalYm GmbH
See details and how to joinNCT07098988 · EU 2024-516792-32-01 - 3. fázisTaking peopleA Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Where
- Berlin, Cologne, Dresden, Frankfurt am Main, Halle, Hamburg
- Életkor
- 18 év and over
- People
- 480 worldwide
- Run by
- Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT07218146 - 3. fázisNot yet taking people in NémetországPD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%
- Where
- Aachen, Augsburg, Berlin, Cologne, Dresden, Erlangen, Frankfurt am Main, Frankfurt Am Main, Giessen, Grosshansdorf, Heidelberg, Mainz, Mannheim, Munich, Oldenburg, Regensburg, Stuttgart, Tuebingen, Wuerzburg
- Életkor
- 18 év and over
- People
- 406
- Run by
- German Cancer Research Center
See details and how to joinNCT07877584 · EU 2026-525387-18-00 - 1/2. fázisNot yet taking people in NémetországPET imaging For eaRly predictiOn of respoNse to neoadjuvanT tReatment in lUNg caNcER
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Radboud universitair medisch centrum Stichting
See details and how to join2025-524791-30-00 - 1. fázisTaking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Berlin, Ulm, Wuerzburg
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - 3. fázisFelfüggesztveSafety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Where
- Berlin, Bonn, Chemnitz, Duesseldorf, Esslingen am Neckar, Freiburg im Breisgau, Gauting, Gera, Grosshansdorf, Halle (saale), Kempten (Allgau), Luebeck, Mainz, Munich, Neuss, Nuremberg, Wuppertal
- Életkor
- 18 év and over
- People
- 621 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06712355 · EU 2024-515765-34-00 - 2. fázisTaking peopleAn Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Exon 20 Insertion and Uncommon/Single or Compound Epidermal Growth Factor Receptor Mutations
- Where
- Dresden, Giessen, Kassel
- Életkor
- 18 év and over
- People
- 117 worldwide
- Run by
- Taiho Oncology Inc.
See details and how to join2023-503865-48-00 - 2/3. fázisNot yet taking people in NémetországIZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy
- Where
- Berlin, Chemnitz, Cologne, Donauwoerth, Esslingen am Neckar, Gauting, Hamburg, Kassel, Kiel, Stuttgart, Ulm
- Életkor
- 18 év and over
- People
- 173 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2025-521908-22-00 - 3. fázisFelfüggesztveA Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
- Where
- Cologne, Frankfurt am Main, Giessen, Loewenstein
- Életkor
- 18 év and over
- People
- 360 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07128199 · EU 2025-521775-31-00 - 2. fázisNot yet taking people in NémetországA Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)
- Where
- Cologne, Hamburg, Moers
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07871214 - 1. fázisTaking peopleStudy of Elironrasib (RMC-6291) and Daraxonrasib (RMC-6236) With Other Anti-Cancer Agents in Patients With RAS G12C-Mutated NSCLC - Subprotocol A
- Where
- Berlin, Cologne, Dresden, Frankfurt Am Main, Heidelberg, Immenhausen, Moers
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2023-509571-16-00 - No phaseTaking peopleClinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
- Where
- Oldenburg
- Életkor
- 18 év and over
- People
- 14 500
- Run by
- AIO-Studien-gGmbH
See details and how to joinNCT02622581 - No phaseTaking peopleEuropean Real-World Registry for Use of the Ion Endoluminal System
- Where
- Berlin, Hemer, Wiesbaden
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Intuitive Surgical
See details and how to joinNCT06923774 - 1/2. fázisTaking peopleA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Where
- Berlin, Essen, Mainz, München, Tübingen
- Életkor
- 18 év and over
- People
- 1438 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Essen
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - 3. fázisTaking peopleSymbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Where
- Aschaffenburg, Berlin, Chemnitz, Duesseldorf, Frankfurt am Main, Georgsmarienhuette, Gera, Grosshansdorf, Halle (saale), Hemer, Kassel, Loewenstein, Luebeck, Moenchengladbach, Munich, Traunstein, Ulm
- Életkor
- 18 év and over
- People
- 1410 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222566 · EU 2025-523461-17-01 - 2/3. fázisNot yet taking people in NémetországSymbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
- Where
- Duesseldorf, Frankfurt am Main
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Pfizer
See details and how to joinNCT07226999 · EU 2025-523522-41-00 - 1/2. fázisTaking peopleSymbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Where
- Düsseldorf, Frankfurt am Main, Freiburg im Breisgau
- Életkor
- 18 év and over
- People
- 162 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227298 · EU 2025-523526-40-00